학술논문
'학술논문'
에서 검색결과 179건 | 목록
1~10
Academic Journal
Pérol M; Chouaid C; Pérol D; Barlési F; Gervais R; Westeel V; Crequit J; Léna H; Vergnenègre A; Zalcman G; Monnet I; Le Caer H; Fournel P; Falchero L; Poudenx M; Vaylet F; Ségura-Ferlay C; Devouassoux-Shisheboran M; Taron M; Milleron B
Journal of Clinical Oncology; 10/1/2012, Vol. 30 Issue 28, p3516-3524, 9p
Academic Journal
Wu X; Ye Y; Rosell R; Amos CI; Stewart DJ; Hildebrandt MA; Roth JA; Minna JD; Gu J; Lin J; Buch SC; Nukui T; Ramirez Serrano JL; Taron M; Cassidy A; Lu C; Chang JY; Lippman SM; Hong WK; Spitz MR
Academic Journal
Ramirez de Molina A; Sarmentero-Estrada J; Belda-Iniesta C; Tarón M; Ramirez de Molina V; Cejas P; Skrzypski M; Gallego-Ortega D; Castro J; Casado E; García-Cabezas MA; Sánchez JJ; Nistol M; Rosell R; González-Barón M; Lacal JC
Academic Journal
Cobo M; Isla D; Massuti B; Montes A; Sanchez JM; Provencio M; Viñolas N; Paz-Ares L; Lopez-Vivanco G; Muñoz MA; Felip E; Alberola V; Camps C; Domine M; Sanchez JJ; Sanchez-Ronco M; Danenberg K; Taron M; Gandara D; Rosell R
Journal of Clinical Oncology; 7/1/2007, Vol. 25 Issue 19, p2747-2754, 8p
Academic Journal
Johnson JP; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Focken T; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Khakh K; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Tari PK; In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Dube C; In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Goodchild SJ; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Andrez JC; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Bankar G; In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Bogucki D; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada.; Burford K; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Chang E; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Chowdhury S; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Dean R; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; de Boer G; Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada.; Decker S; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Dehnhardt C; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Feng M; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Gong W; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Grimwood M; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Hasan A; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Hussainkhel A; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Jia Q; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Lee S; Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada.; Li J; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Lin S; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Lindgren A; Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada.; Lofstrand V; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Mezeyova J; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Namdari R; Translational Drug Development, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Nelkenbrecher K; In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Shuart NG; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Sojo L; Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada.; Sun S; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Taron M; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Waldbrook M; In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Weeratunge D; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Wesolowski S; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Williams A; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Wilson M; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Xie Z; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Yoo R; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Young C; In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Zenova A; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Zhang W; Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Cutts AJ; Scientific Affairs, Xenon Pharmaceuticals, Inc, Burnaby BC, Canada.; Sherrington RP; Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Pimstone SN; Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Winquist R; Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Cohen CJ; Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada.; Empfield JR; Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada.
Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Academic Journal
Challa VR; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.; Kwon D; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.; Taron M; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.; Fan H; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.; Kang B; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.; Wilson D; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.; Haeckl FPJ; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.; Keerthisinghe S; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.; Linington RG; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.; Britton R; Department of Chemistry, Simon Fraser University Burnaby British Columbia V5A 1S6 Canada rbritton@sfu.ca.
Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101545951 Publication Model: Electronic Cited Medium: Print ISSN: 2041-6520 (Print) Linking ISSN: 20416520 NLM ISO Abbreviation: Chem Sci Subsets: PubMed not MEDLINE
Editorial & Opinion
Taron M; SEFF Spanish Society of Pharmacogenetics and Pharmacogenomics (SEFF), Madrid, Spain.; Synlab Diagnósticos Globales SAU, Alcobendas (Madrid), Spain.; Llerena A; SEFF Spanish Society of Pharmacogenetics and Pharmacogenomics (SEFF), Madrid, Spain.; ESPT European Society for Pharmacogenomics and Personalised Therapy (ESPT), Milano, Italy.; INUBE Extremadura Biosanitary University Research Institute, Badajoz University Hospital, Pharmacogenetics and Personalized Medicine Unit, Badajoz, Spain.; Manolopoulos VG; ESPT European Society for Pharmacogenomics and Personalised Therapy (ESPT), Milano, Italy.; Laboratory of Pharmacology, Medical School, Democritus University of Thrace, and Clinical Pharmacology and Pharmacogenetics Unit, Academic General Hospital of Evros, Alexandroupolis, Greece.; Rodriguez-Antona C; SEFF Spanish Society of Pharmacogenetics and Pharmacogenomics (SEFF), Madrid, Spain.; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain.; Stankovic S; ESPT European Society for Pharmacogenomics and Personalised Therapy (ESPT), Milano, Italy.; Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia.; van Schaik RHN; ESPT European Society for Pharmacogenomics and Personalised Therapy (ESPT), Milano, Italy.; Department Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Publisher: De Gruyter Country of Publication: Germany NLM ID: 101653409 Publication Model: Electronic Cited Medium: Internet ISSN: 2363-8915 (Electronic) Linking ISSN: 23638915 NLM ISO Abbreviation: Drug Metab Pers Ther Subsets: MEDLINE
Academic Journal
Taron M; Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisboa, Portugal.; Nunes C; Departamento de Estatística, Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisboa, Portugal.; Maia T; Departamento de Saúde Mental, Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisboa, Portugal.
Publisher: Associação Brasileira de Psiquiatria Country of Publication: Brazil NLM ID: 100895975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1809-452X (Electronic) Linking ISSN: 15164446 NLM ISO Abbreviation: Braz J Psychiatry Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Tarón M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어